Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Lau

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature|April 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradationSebastien Coassolo, Nairie Michaelian, Timurs Maculins, et al.
Cancer Research|August 17, 2019
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung CancerSteffan Vartanian, James Lee, Christiaan Klijn, et al.
Nature Chemical Biology|May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cellsMaia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature|April 15, 2026
Template-driven scaffolding of SCF<sup>FBXO42</sup> regulates PP2A degradationSebastien Coassolo, Nairie Michaelian, Timurs Maculins, et al.
Cancer Research|August 17, 2019
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung CancerSteffan Vartanian, James Lee, Christiaan Klijn, et al.
Nature Chemical Biology|May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cellsMaia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
Pageof 2